1.22
3.39%
0.04
Handel nachbörslich:
1.22
Schlusskurs vom Vortag:
$1.18
Offen:
$1.22
24-Stunden-Volumen:
17,748
Relative Volume:
0.53
Marktkapitalisierung:
$56.10M
Einnahmen:
$81.76M
Nettoeinkommen (Verlust:
$-23.96M
KGV:
-1.00
EPS:
-1.22
Netto-Cashflow:
$-7.50M
1W Leistung:
-3.17%
1M Leistung:
-8.27%
6M Leistung:
-7.58%
1J Leistung:
-8.27%
Theratechnologies Inc Stock (THTX) Company Profile
Firmenname
Theratechnologies Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie THTX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
THTX | 1.22 | 56.10M | 81.76M | -23.96M | -7.50M | -1.22 |
VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Theratechnologies Inc Stock (THTX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2022-11-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
2021-07-29 | Herabstufung | Canaccord Genuity | Buy → Hold |
Theratechnologies Inc Aktie (THTX) Neueste Nachrichten
Theratechnologies Inc. (NASDAQ:THTX) Short Interest Up 26.8% in October - MarketBeat
Theratechnologies (TSE:TH) Share Price Passes Above Fifty Day Moving AverageTime to Sell? - MarketBeat
Net Present Value Model: Theratechnologies Inc’s Sudocetaxel Zendusortide - GlobalData
Theratechnologies (TSE:TH) Stock Passes Below Fifty Day Moving AverageTime to Sell? - MarketBeat
Short Interest in Theratechnologies Inc. (NASDAQ:THTX) Rises By 226.0% - MarketBeat
Closing Bell: Theratechnologies Down On Monday (TH) - Barchart
THTX upgraded at Research Capital - Cantech Letter
Theratechnologies (TSE:TH) Stock Price Crosses Above 50 Day Moving AverageHere's Why - MarketBeat
Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV - The Manila Times
Theratechnologies reports use of HIV drug in severe cases - Investing.com
Theratechnologies reports use of HIV drug in severe cases By Investing.com - Investing.com South Africa
Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance - GlobeNewswire
Theratechnologies Inc. Forecasted to Earn FY2024 Earnings of $0.04 Per Share (NASDAQ:THTX) - Defense World
Cantor Fitzgerald Weighs in on Theratechnologies Inc.'s FY2024 Earnings (NASDAQ:THTX) - MarketBeat
Earnings call: Theratechnologies reports Q3 profit, raises EBITDA guidance - Investing.com
Theratechnologies (NASDAQ:THTX) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Theratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Theratechnologies (TSE:TH) Stock Passes Above 50 Day Moving AverageWhat's Next? - MarketBeat
Theratechnologies Inc (THTX) Q3 2024 Earnings Call Highlights: Strong Profitability Amid ... - Yahoo Finance
Theratechnologies: Fiscal Q3 Earnings Snapshot - mySA
Theratechnologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024 - Marketscreener.com
Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024 - GlobeNewswire
Theratechnologies Inc. Revises Earnings Guidance for the Fiscal Year 2024 - Marketscreener.com
Earnings to Watch: Theratechnologies Inc (TSX:TH) Reports Q3 202 - GuruFocus.com
Theratechnologies to Present Data at IDWeek 2024 - GlobeNewswire
Theratechnologies (TH) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Theratechnologies Inc. (NASDAQ:THTX) Short Interest Update - MarketBeat
Theratechnologies (TSE:TH) Shares Pass Below Two Hundred Day Moving Average of $1.83 - MarketBeat
Theratechnologies (TSE:TH) Stock Price Crosses Below Two Hundred Day Moving Average of $1.83 - Defense World
Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update - Brantford Expositor
Theratechnologies Braces for Supply Disruption - TipRanks
Thermon Group Holdings, Inc. (NYSE:THR) Shares Purchased by Victory Capital Management Inc. - Defense World
Thryv Holdings director Amer acquires $22,152 in company stock - Investing.com India
Selling Buzz: Tenet Healthcare Corp. [THC] Principal Accounting Officer Ramsey R. Scott sells 11,599 shares of the company – Knox Daily - Knox Daily
Tenet Healthcare stock hits 52-week high at $166.9 amid robust growth - Investing.com
Insider Selling: Gentherm Incorporated (NASDAQ:THRM) CEO Sells 4,402 Shares of Stock - MarketBeat
Hellenic Telecommunications Organization (OTCMKTS:HLTOY) Sets New 52-Week High at $8.50 - MarketBeat
Tenet Healthcare (NYSE:THC) Sets New 52-Week High at $167.29 - MarketBeat
Hercules Capital (HTGC) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance
Gentherm CEO sells over $750k in company stock - Investing.com India
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
Teralys Capital says it “should” hit $570-million fund-of-funds target by end of yearBetaKit - BetaKit - Canadian Startup News
Ternium: Still Not A Buy As Near-Term Growth Prospects Remain Unfavorable - Seeking Alpha
Theratechnologies Faces Potential Supply Disruption For Its Top Selling Drug, Warns of Revenue Impact Due To Manufacturing Delays - AOL
Finanzdaten der Theratechnologies Inc-Aktie (THTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):